Clinical trial disclosure

LEO Pharma is a patient-centric company, and for us that entails being transparent about the results from our clinical trials, so that we can enable patients and healthcare professionals to make informed decisions about treatment.

LEO Pharma recognises the public health benefits associated with making clinical trials results available. By ensuring that the latest clinical information is available we can continue to advance the scientific understanding of the disease areas covered by the clinical trials sponsored by LEO Pharma.

Results from clinical trials dating back to 1990 are available on this website. Our commitments to transparency are outlined in the LEO Pharma Position on Public Access to Clinical Trials Information

Besides compliance with legal requirements,  LEO Pharma complies with requirements from the International Committee of Medical Journal Editors (ICMJE) and with the positions of IFPMA, EFPIA, JPMA and PhRMA on disclosure of information about clinical trials and trial reports.
 

Trial information and trial results from LEO Pharma sponsored clinical trials are available on the following publicly accessible websites ClinicalTrials.gov and the EU Clinical Trials Register

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.